News
Reported Earlier, Pharming Announces Completion of Enrollment in Pediatric Clinical Trial of Leniolisib
8 Apr 24
News
HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target
14 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Earnings Scheduled For March 14, 2024
14 Mar 24
Earnings
Pharming Group Expects 2024 Total Revenue Of $280M-$295M
14 Mar 24
Earnings, News, Guidance
Pharming Q4 EPS $0.00 Up From $(0.02) YoY, Sales $81.20M Up From $54.62M YoY
14 Mar 24
Earnings, News
Press releases
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
24 Apr 24
News, Press Releases
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
8 Apr 24
News, Press Releases
Pharming Group to participate in April investor conferences
3 Apr 24
News, Press Releases
Pharming Group reports fourth quarter and full year 2023 financial results
14 Mar 24
Earnings, Press Releases
Pharming Group to report fourth quarter and full year 2023 financial results on March 14
29 Feb 24
Press Releases
Pharming Group to participate in February investor conferences
8 Feb 24
Press Releases